| 1 |
34681173 | Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer Cells. | 2021 Sep 22 |
1 |
| 2 |
26534836 | Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel. | 2016 Jan |
1 |
| 3 |
26993769 | Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer. | 2016 May 3 |
3 |
| 4 |
25846650 | IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance. | 2015 Jun |
1 |
| 5 |
24675421 | Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition. | 2014 Mar 15 |
1 |
| 6 |
22322152 | E Platinum, a newly synthesized platinum compound, induces autophagy via inhibiting phosphorylation of mTOR in gastric carcinoma BGC-823 cells. | 2012 Apr 5 |
1 |
| 7 |
19428505 | Role of MAPKs in platinum-induced neuronal apoptosis. | 2009 Mar |
1 |
| 8 |
14529677 | Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions. | 2003 Oct |
1 |
| 9 |
12181446 | Regulation of platinum-compound cytotoxicity by the c-Jun N-terminal kinase and c-Jun signaling pathway in small-cell lung cancer cells. | 2002 Sep |
3 |
| 10 |
9484843 | Cisplatin induces a persistent activation of JNK that is related to cell death. | 1998 Jan 29 |
1 |